Market research and business consulting firm Frost & Sullivan announced on Tuesday that Indonesia-based PT Prodia Diacro Laboratories (Prodia the CRO) has received the 2026 Southeast Asian Customer Value Leadership Recognition in the contract research organisation (CRO) industry for its achievements in customer-centric service delivery, integrated clinical research capabilities, and operational excellence.
According to Frost & Sullivan, the recognition highlights Prodia the CRO's ability to deliver measurable customer value while strengthening Indonesia's position in Southeast Asia's evolving clinical research landscape.
Prodia the CRO brings together regulatory consulting, clinical trial management, site management organisation services, central laboratory support, consumer product clinical assessment, and pharmacovigilance capabilities. The integrated model reduces vendor fragmentation, streamlines communication, and enables sponsors to access coordinated support across the clinical research life cycle.
Sophos IRB and ALCMI partner to support lung cancer research
Innovent Biologics achieves primary study endpoint for inactive thyroid eye disease antibody
argenx reports positive Phase 2 results for FB102 in coeliac disease
Vir Biotechnology's VIR-5500 receives FDA Fast Track designation for prostate cancer
FDA accepts Bayer's application for KERENDIA in chronic kidney disease without diabetes
WuXi AppTec awarded EcoVadis gold medal for third year
Suzhou Ribo Life Science submits Phase I Clinical Trial Application for RBD3133 in EU
Roche Diagnostics supplies molecular testing instruments to support Ebola response in the DRC